282 related articles for article (PubMed ID: 16732771)
1. Primary prevention of neural tube defects with folate in Western Australia: the value of the Western Australian Birth Defects Registry.
Bower C
Congenit Anom (Kyoto); 2006 Jun; 46(2):118-21. PubMed ID: 16732771
[TBL] [Abstract][Full Text] [Related]
2. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification.
Bower C; D'Antoine H; Stanley FJ
Birth Defects Res A Clin Mol Teratol; 2009 Apr; 85(4):269-73. PubMed ID: 19180646
[TBL] [Abstract][Full Text] [Related]
3. Trends in neural tube defects in Western Australia in Indigenous and non-Indigenous populations.
Bower C; Eades S; Payne J; D'Antoine H; Stanley F
Paediatr Perinat Epidemiol; 2004 Jul; 18(4):277-80. PubMed ID: 15255881
[TBL] [Abstract][Full Text] [Related]
4. Promotion of folate for the prevention of neural tube defects: who benefits?
Bower C; Miller M; Payne J; Serna P
Paediatr Perinat Epidemiol; 2005 Nov; 19(6):435-44. PubMed ID: 16269071
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of neural tube defects in Australia prior to mandatory fortification of bread-making flour with folic acid.
Abeywardana S; Bower C; Halliday J; Chan A; Sullivan EA
Aust N Z J Public Health; 2010 Aug; 34(4):351-5. PubMed ID: 20649773
[TBL] [Abstract][Full Text] [Related]
6. Case for mandatory fortification of food with folate in Australia, for the prevention of neural tube defects.
Bower C; Stanley FJ
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):842-3. PubMed ID: 15523662
[TBL] [Abstract][Full Text] [Related]
7. Preventing neural tube defects in Europe: a missed opportunity.
Busby A; Abramsky L; Dolk H; Armstrong B; Addor MC; Anneren G; Armstrong N; Baguette A; Barisic I; Berghold A; Bianca S; Braz P; Calzolari E; Christiansen M; Cocchi G; Daltveit AK; De Walle H; Edwards G; Gatt M; Gener B; Gillerot Y; Gjergja R; Goujard J; Haeusler M; Latos-Bielenska A; McDonnell R; Neville A; Olars B; Portillo I; Ritvanen A; Robert-Gnansia E; Rösch C; Scarano G; Steinbicker V
Reprod Toxicol; 2005; 20(3):393-402. PubMed ID: 15927445
[TBL] [Abstract][Full Text] [Related]
8. Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment.
Botto LD; Lisi A; Bower C; Canfield MA; Dattani N; De Vigan C; De Walle H; Erickson DJ; Halliday J; Irgens LM; Lowry RB; McDonnell R; Metneki J; Poetzsch S; Ritvanen A; Robert-Gnansia E; Siffel C; Stoll C; Mastroiacovo P
Birth Defects Res A Clin Mol Teratol; 2006 Oct; 76(10):693-705. PubMed ID: 17029289
[TBL] [Abstract][Full Text] [Related]
9. Dietary folate and nonneural midline birth defects: no evidence of an association from a case-control study in Western Australia.
Bower C; Stanley FJ
Am J Med Genet; 1992 Nov; 44(5):647-50. PubMed ID: 1481827
[TBL] [Abstract][Full Text] [Related]
10. Ascertainment of pregnancies terminated because of birth defects: effect on completeness of adding a new source of data.
Bower C; Ryan A; Rudy E
Teratology; 2001 Jan; 63(1):23-5. PubMed ID: 11169551
[TBL] [Abstract][Full Text] [Related]
11. Does periconceptional multivitamin use reduce the risk of neural tube defects associated with other birth defects? data from two population-based case-control studies.
Khoury MJ; Shaw GM; Moore CA; Lammer EJ; Mulinare J
Am J Med Genet; 1996 Jan; 61(1):30-6. PubMed ID: 8741914
[TBL] [Abstract][Full Text] [Related]
12. Rates of selected birth defects in relation to folic acid fortification, Hawaii, 1986-2002.
Forrester MB; Merz RD
Hawaii Med J; 2005 Dec; 64(12):300, 302-5. PubMed ID: 16438020
[TBL] [Abstract][Full Text] [Related]
13. [Differences in folic-acid policy and the prevalence of neural-tube defects in Europe; recommendations for food fortification in a EUROCAT report].
Meijer WM; de Walle HE
Ned Tijdschr Geneeskd; 2005 Nov; 149(46):2561-4. PubMed ID: 16320666
[TBL] [Abstract][Full Text] [Related]
14. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002.
Ward M; Hutton J; Mc Donnell R; Bachir N; Scallan E; O'Leary M; Hoey J; Doyle A; Delany V; Sayers G
Ir Med J; 2004 Oct; 97(9):274-6. PubMed ID: 15568585
[TBL] [Abstract][Full Text] [Related]
16. Are the recommendations on the prevention of neural tube defects working?
Stoll C; Alembik Y; Dott B
Eur J Med Genet; 2006; 49(6):461-5. PubMed ID: 16877057
[TBL] [Abstract][Full Text] [Related]
17. Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: findings from a multi-state population-based study.
Canfield MA; Collins JS; Botto LD; Williams LJ; Mai CT; Kirby RS; Pearson K; Devine O; Mulinare J;
Birth Defects Res A Clin Mol Teratol; 2005 Oct; 73(10):679-89. PubMed ID: 16240378
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of neural tube defects in Israel: the effect of the recommendation for periconceptional folic acid.
Zlotogora J; Amitai Y; Leventhal A
Isr Med Assoc J; 2006 Sep; 8(9):601-4. PubMed ID: 17058407
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of a neural tube defect recurrence-prevention program.
Grosse SD; Ouyang L; Collins JS; Green D; Dean JH; Stevenson RE
Am J Prev Med; 2008 Dec; 35(6):572-7. PubMed ID: 18845415
[TBL] [Abstract][Full Text] [Related]
20. NTD prevalences in central California before and after folic acid fortification.
Chen BH; Carmichael SL; Selvin S; Abrams B; Shaw GM
Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):547-52. PubMed ID: 18496833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
